Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hasbro, Inc. (HAS) vs GeneDx Holdings Corp (WGS) Price & Performance

Hasbro, Inc.Trade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Hasbro, Inc. vs GeneDx Holdings Corp — how do they compare? Hasbro, Inc. trades at $96.3 (market cap $13.69B), while GeneDx Holdings Corp trades at $82.39 (market cap $2.44B). The key difference: Hasbro, Inc. is far larger — about 5.6× GeneDx Holdings Corp's market cap, and Hasbro, Inc. pays a 2.89% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

HASWGS
Market Cap
$13.69B$2.44B
Sector
Consumer CyclicalTechnology
52-Week High
$105.88$167.51
52-Week Low
$70.95$34.51
Enterprise Value
$15.88B$2.48B
Dividend Yield
2.89%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hasbro, Inc.

Hasbro (HAS) trades at $96.19, up 1.8% today, with a bullish technical outlook from moving averages and a consensus analyst price target of $104.90. Recent earnings beats in Q4 2025, Q1 2026, and Q2 2026 highlight strong operational performance, though 2025 net income was negative due to a one-time tax charge. Revenue growth is projected to rebound to $5.0B in 2026, with a net income margin of 16%, supported by strength in the Wizards of the Coast segment.

The stock offers upside potential from earnings momentum and dividend yield, but risks include high debt levels, margin pressures, and competitive threats. Institutional buying and positive media coverage on franchises like Magic: The Gathering provide tailwinds, yet volatility from tariffs and execution risks warrants caution for investors seeking growth in the consumer discretionary sector.

GeneDx Holdings Corp

GeneDx Holdings Corp (WGS) trades at $82.36, up 5.75% in 24 hours, with a bullish technical signal and strong analyst support. Recent Q2 2026 results beat expectations with $0.01 EPS and record testing volumes, though net income margins remain negative. The stock faces class action litigation risks but benefits from institutional buying and new product launches.

Outlook is mixed: bullish technicals and 91% buy ratings suggest upside to the $90 high target, but negative profitability and legal overhangs pose risks. Investors should weigh growth potential against financial sustainability and litigation outcomes.

Returns comparison

Trailing returns across standard periods

About Hasbro, Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. Ownership stakes in Discovery Family, which offers programming around Hasbro brands, and owned production capabilities from Entertainment One help bolster Hasbro's multichannel presence. The firm acquired Entertainment One in 2019, bolting on popular properties like Peppa Pig and PJ Masks, and has plans to tie up with Dungeons & Dragons Beyond in 2022, offering the firm access 10 million digital tabletop players.

Read more on HAS

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS